Chartwell Pharmaceuticals
Thomas Morelli is an accomplished professional with extensive experience in pharmaceutical operations and supply chain management. Currently serving as Vice President and General Manager at Chartwell Pharmaceuticals since September 2023, Thomas previously held the same title at Akorn Pharmaceuticals from May 2015 to September 2023, where expertise in developing and marketing specialty pharmaceutical products was demonstrated. Thomas has held prominent leadership roles in various organizations, including Hi-Tech Pharmacal Co., Inc., where responsibilities included overseeing distribution operations and compliance with regulatory agencies. Education includes a Bachelor's Degree in Business Management from Empire State University, currently in progress.
This person is not in any offices
Chartwell Pharmaceuticals
CHARTING A COURSE TO WELLNESS Chartwell Pharmaceuticals is a US-based development, manufacturing and commercial organization located in Congers, New York. Our facility produces prescription pharmaceutical products with a commitment to superior quality, compliance, and customer service. Chartwell Pharmaceuticals has a long history as a preferred manufacturing partner for prescription solid dosage products in tablet, capsule, and powders forms. Recent expansion now adds capabilities for suspensions, enemas and liquids manufacturing - including Unit Dose cups. Our rooms are large, our ceilings are high, and facilities are pristine. Our exceptional hands-on leadership team and technical staff bring decades of pharmaceutical industry experience in manufacturing and analytical services for development, scale-up, transferring, changing, launching, and supplying products. Under our own Chartwell labels, our mission is to provide a consistent, timely and quality product supply to our pharmacy customers and their patients. Our current portfolio stands at over 250 Orange Book listed ANDAs and NDAs, with an aggressive asset development and acquisition program in place. Supported by Chartwell Labs, our Formulations and Analytical team, we are quickly continuing to broaden our line through commercial Chartwell-labeled branding. Chartwell Pharmaceuticals is proud to be manufacturing "Made in the USA" products.